BLOG

Researchers have shown that a synthetic IL-9 receptor allows anti-cancer

A major drawback of CRISPR-Cas9-mediated genome editing is that not

Genetically modified immune cells successfully target specific cancer cells that

Breakthrough findings were presented at the 2022 ASCO Annual Meeting

It is a pity that non integrating lentiviral vectors are

In a recent study, a team of researchers used a

With a $17 million grant, UCSF Benioff Children’s Hospital in

The FDA has granted accelerated designation to PRGN-3006 for the

Mucopolysaccharidosis I is caused by mutations in the gene for